Aptahem AB (APTA)

Currency in SEK
0.7140
+0.0440(+6.57%)
Closed·
APTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.67200.7160
52 wk Range
0.50002.4000
Key Statistics
Bid/Ask
0.672 / 0.714
Prev. Close
0.67
Open
0.712
Day's Range
0.672-0.716
52 wk Range
0.5-2.4
Volume
5.37K
Average Volume (3m)
38.54K
1-Year Change
-38.4483%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
12/02/2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
829K / --
EPS Revisions
Last 90 days

Compare APTA to Peers and Sector

Metrics to compare
APTA
Peers
Sector
Relationship
P/E Ratio
−2.7x−3.0x−0.5x
PEG Ratio
−0.05−0.070.00
Price/Book
0.3x5.9x2.6x
Price / LTM Sales
6.7x13.6x3.1x
Upside (Analyst Target)
-127.1%55.1%
Fair Value Upside
Unlock13.8%7.2%Unlock

Aptahem AB (publ), a biotechnology company, engages in the development of ribonucleic acid-based pharmaceuticals in Sweden. The company’s lead product candidate is Apta-1, which is in Phase I clinical trial for the treatment of patients with sepsis/septic shock and severe inflammatory conditions, as well as to prevent organ and tissue damages in life-threatening conditions. It also develops Apta-2 which is in preclinical stage for the treatment of inflammation; and Apta-3 which is in discovery stage. The company has a collaboration with Hongene Biotech for the manufacturing of RNA and oligonucleotides. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
352.52K1.68%236.19K
Other Institutional Investors
2.84M13.53%1.90M
Public Companies & Retail Investors
17.78M84.79%11.91M
Total
20.97M100.00%14.05M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Investment Aktiebolaget Balticum4.83%1,012,561678
Avanza Fonder AB4.39%921,305617

FAQ

What Is the Aptahem AB (Spotlight: APTA) Share Price Today?

The Aptahem AB stock price today is 0.7140 SEK.

What Stock Exchange Does Aptahem AB (APTA) Trade On?

Aptahem AB is listed and trades on the Spotlight Stock Market.

What Is the Ticker (Stock Symbol) for Aptahem AB?

The stock symbol (also called a 'ticker') for Aptahem AB is "APTA."

What Is the Current Aptahem AB Market Capitalisation?

As of today, Aptahem AB (Spotlight: APTA) market cap is 17.3800M SEK.

What Is Aptahem AB's (APTA) Earnings Per Share (TTM)?

The Aptahem AB EPS is currently -0.3095 (Trailing Twelve Months).

Is APTA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Aptahem AB moving averages and other technical indicators, the daily buy/sell signal for APTA stock is Neutral.

How Many Times Has Aptahem AB Stock Split?

Aptahem AB has split 3 times. (See the APTA stock split history page for full effective split date and price information.)

How Many Employees Does Aptahem AB Have?

Aptahem AB has 3 employees, based on their latest Companies House report.

What is the current trading status of Aptahem AB (Spotlight: APTA)?

As of 20/05/2026, Aptahem AB (APTA) is trading at a share price of 0.7140 SEK, with a previous close of 0.6700 SEK. The stock has fluctuated within a day range of 0.6720 SEK to 0.7160 SEK, while its 52-week range spans from 0.5000 SEK to 2.4000 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.